P. Grivas
{"title":"免疫检查点抑制剂和新型药物治疗转移性尿路上皮癌的现状和未来展望","authors":"P. Grivas","doi":"10.17925/ohr.2019.15.2.68","DOIUrl":null,"url":null,"abstract":"<p />","PeriodicalId":87332,"journal":{"name":"Oncology & hematology review","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2019-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Immune Checkpoint Inhibitors and Novel Agents in the Treatment of Metastatic Urothelial Cancer—Current Status and Future Perspectives\",\"authors\":\"P. Grivas\",\"doi\":\"10.17925/ohr.2019.15.2.68\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p />\",\"PeriodicalId\":87332,\"journal\":{\"name\":\"Oncology & hematology review\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2019-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Oncology & hematology review\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.17925/ohr.2019.15.2.68\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Oncology & hematology review","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.17925/ohr.2019.15.2.68","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0